Description

The purpose of this Notice of Amendment is to notify about the addition of hydroquinone or its derivatives to the Prescription Drug List (PDL) for human use when sold in concentrations greater than 2% in topical products.

Resources

Name	Format	Description	Link
Notice - Prescription Drug List (PDL): Hydroquinone	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/notice-prescription-drug-list-2018-08-22.html
Notice - Prescription Drug List (PDL): Hydroquinone	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/avis-concernant-modifications/avis-liste-drogues-ordonnance-2018-08-22.html

Tags

Topics

Categories